Showing 1 - 10 of 6,451
crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …
Persistent link: https://www.econbiz.de/10012802183
-deals as part of pharmaceutical patent settlements in the European Union. First, this paper critically discusses and compares … side-deals that were part of the patent settlements in the Servier case, which is currently pending on appeal. Second, the … outlined, focusing on the CJEU’s analysis of the side-deals that were part of the patent settlements at issue. The core …
Persistent link: https://www.econbiz.de/10013248610
Persistent link: https://www.econbiz.de/10010493959
of agreements by which brand-name drug companies pay generics to settle patent litigation and delay entering the market … of the patent" test applied by the dissent and several appellate courts — would have meant "game over" for challenges to …
Persistent link: https://www.econbiz.de/10014155650
crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …
Persistent link: https://www.econbiz.de/10013309494
biologic patents expire. As early biologics are starting to go off-patent, this regulatory mix-up is having a notable impact on …
Persistent link: https://www.econbiz.de/10014059336
vaccines are claimed in myriad – not Myriad – patents and patent applications, many of which are destined to be litigated over … their owners. While the world waits for this storm of patent litigation, federal courts continue to be busy with ownership … as top tens compiled by others. However, to quote an expression commonly heard in courts hearing patent cases, à chacun …
Persistent link: https://www.econbiz.de/10014255494
In any assessment of the R&D capabilities of Indian companies, their patent holdings would have to be examined. Here we … Australia being much smaller ones. However, the companies have unpredictable patterns of patent holdings across these four …
Persistent link: https://www.econbiz.de/10014130598
In order to help reduce drug prices, governments in countries such as India are devising policies to help local biotech companies. These companies are also initiating original drug discovery programmes. How much should these governments and companies be concerned about patents? We have...
Persistent link: https://www.econbiz.de/10014130650
Persistent link: https://www.econbiz.de/10012039349